Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 121
Filter
1.
Transplant Proc ; 38(2): 426-9, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16549138

ABSTRACT

INTRODUCTION: Various immunological, metabolic, and technical factors render pediatric recipients with end-stage renal disease unique from their adult counterparts. In addition, the potential for complications after renal transplantation is far greater in children than in adults. In this study, we retrospectively analyzed 83 pediatric recipients who underwent kidney transplantation at our institution from 1975 to 2004. MATERIALS AND METHODS: From November 1975 to December 2004, 1523 renal transplantations were performed at our institution with 56 procedures in 83 pediatric patients (44 boys and 39 girls; age range, 7 to 17 years; mean age, 14.9 +/- 2.2 years). RESULTS: Long-term follow-up revealed the following morbidities in 14 (16.3%) recipients: lymphocele in 7 (8.1%) patients, perirenal hematoma in 2 (2.3%), graft renal artery stenosis in 2 (2.3%), ureteral stenosis in 2 (2.3%), and ureteral anastomotic leak in 1 (1.2%). Six (7.2%) recipients with a functioning graft died during follow-up (five deaths were infection related, and the cause of one death was unknown). Five grafts failed (four for immunological reasons and one as a result of recurrent disease). The 1-, 3-, 5-year patient and graft survival rates were 98%, 93%, 92% and 91%, 78%, 67% for living related transplantations versus 98%, 91%, 90% and 92%, 76%, 65% for cadaveric transplantations, respectively. DISCUSSION: Better outcomes for renal transplantation in children may be obtained by strict adherence to precise surgical techniques, better immunosuppressive management, and early diagnosis/effective treatment of complications.


Subject(s)
Kidney Diseases/surgery , Kidney Transplantation/statistics & numerical data , Adolescent , Cadaver , Child , Female , Humans , Kidney Diseases/classification , Kidney Transplantation/adverse effects , Living Donors , Male , Postoperative Complications/classification , Retrospective Studies , Tissue Donors , Treatment Failure , Treatment Outcome , Turkey
2.
Transplant Proc ; 37(7): 2915-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16213260

ABSTRACT

Cardiovascular disease is one of the most important causes of morbidity and mortality in children with end-stage renal failure. Chronic inflammation and malnutrition have been suggested to be risk factors for cardiovascular disease. However, to date, biomarkers of inflammation have not been well studied in children. The aim of this study was to investigate the relation between chronic inflammation and cardiovascular risk factors in children on hemodialysis therapy. Twenty-seven patients on hemodialysis (14 girls, 13 boys) of mean age 15.3 +/- 2.4 years and 20 healthy children (13 girls, 7 boys) of mean age 14.3 +/- 2.7 years were included the study. C-reactive protein (CRP), albumin, prealbumin, transferrin, ferritin, and fibrinogen were measured as the markers of inflammation. The levels of CRP, ferritin, and erythrocyte sedimentation rate among hemodialysis patients were significantly higher than those of control subjects (P < .001 for all). Albumin and transferrin levels were found to be lower than those of control group (P = .02 and P < .001, respectively). CRP levels were negatively correlated with albumin, prealbumin, apoprotein A1, HDL, and hemoglobin levels, and positively correlated with erythropoietin/Htc ratios. This study suggests that hemodialyzed children are exposed to chronic inflammation. In addition, CRP may be an indicator of chronic inflammation related to cardiovascular risk factors, such as malnutrition, dyslipidemia, and anemia. In conclusion, we suggest that the risk of cardiovascular disease could be reduced by defining markers of chronic inflammation and malnutrition in hemodialyzed children and by taking necessary measures at an early stage.


Subject(s)
Blood Proteins/analysis , Cardiovascular Diseases/epidemiology , Inflammation , Renal Dialysis/adverse effects , Adolescent , Biomarkers/blood , C-Reactive Protein/analysis , Child , Female , Humans , Kidney Failure, Chronic/therapy , Male , Prealbumin/analysis , Reference Values , Risk Factors , Serum Albumin/analysis
3.
Transplant Proc ; 37(7): 3106-8, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16213321

ABSTRACT

INTRODUCTION: Leptin plays an important role in regulating appetite and energy expenditure and also functions in the neuroendocrine, hematopoietic, and immune systems, among others. Leptin may be involved in modulating bone mineralization. The relationship between leptin and bone mineral density (BMD) is not clear. This study examined the relationship between BMD and serum leptin levels in renal transplant recipients. MATERIALS AND METHODS: Forty-one patients (28 men and 13 women; age 16 to 55 years) were grouped according to percentile of serum leptin level hypoleptinemic (<5th percentile, n = 14), normoleptinemic (between the 5th and 95th percentiles, n = 19), or hyperleptinemic (>95th percentile, n = 8). The patients also were grouped according to lumbar z score) and total femur z scores (>-2 vs <-2 for both). RESULTS: The groups with different leptin statuses were compared with respect to age, sex distribution, and body mass index. Mean lumbar z score and mean lumbar BMD were higher in the hyperleptinemic group than in the normo- and hypoleptinemic groups (P < .05 for all). Considering the 42 patients overall, those with lumbar z scores >-2 had higher mean serum leptin/BMI than those with lumbar z scores <-2 (0.55 +/- 0.65 vs 0.18 +/- 0.23, respectively, P < .05). Serum leptin/BMI ratio was correlated with lumbar z score (r = .38, P < .05) and lumbar BMD (r = .32, P < .05). CONCLUSION: In conclusion, the data indicate that elevated leptin level is associated with increased bone mass at lumbar sites in renal transplant recipients. This suggest that increased leptin has a bone-sparing effect, especially in the lumbar region, in this patient group.


Subject(s)
Bone Density , Kidney Transplantation/physiology , Leptin/blood , Adolescent , Adult , Age Factors , Appetite , Biomarkers/blood , Female , Humans , Male , Middle Aged , Peritoneal Dialysis , Reference Values , Renal Dialysis , Sex Distribution
4.
Clin Rheumatol ; 22(4-5): 265-7, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14576987

ABSTRACT

The pathogenesis of vasculitis is complex and is yet to be fully elucidated, although it is known that inflammatory cells play a major role. Dysregulation of apoptosis and defective clearance of inflammatory cells could lead to the persistence of inflammation and excessive tissue injury. In this study we aimed to investigate Fas (CD95) and apoptosis on peripheral blood (PB) neutrophil and lymphocytes in Henoch-Schonlein purpura, both in the acute phase and after resolution to determine the role of apoptosis in this self-limited vasculitis. Leukocytoclastic vasculitis presenting with Henoch-Schonlein purpura (HSP) was diagnosed according to ACR 1990 criteria and confirmed by skin biopsy. Thirty-seven patients (22 boys, 15 girls) aged 2.5-17 years (9 +/- 3.3) were enrolled in the study. Expression of CD95 and apoptosis were investigated by the annexin/PI method on peripheral blood neutrophils and lymphocytes in both the acute and the resolution phases of the disease. The mean neutrophil and lymphocyte CD95 expression was 65.4 +/- 37.6% and 33.3 +/- 7.3%, respectively, in the acute stage and 62.8 +/- 44.2% and 41 +/- 20%, respectively, in the resolution ( P > 0.05). The percentage of apoptotic peripheral blood neutrophils and lymphocytes as determined by annexin positivity was 13.3 +/- 11.31% and 8.6 +/- 9.5%, respectively, during the acute phase and 4.6 +/- 3.4% and 3.1 +/- 3.1%, respectively, in the resolution (P = 0.002, P = 0.008). These results suggest that increased apoptotic process in the immune effector cells in the acute phase of the disease may play an important role in the early control of inflammatory response and repair in leukocytoclastic vasculitis, thereby contributing to the self-limited nature of the disease.


Subject(s)
Annexin A5/analysis , Apoptosis/physiology , IgA Vasculitis/diagnosis , IgA Vasculitis/immunology , fas Receptor/analysis , Adolescent , Biomarkers/analysis , Child , Child, Preschool , Female , Flow Cytometry , Humans , Male , Probability , Prognosis , Remission, Spontaneous , Risk Assessment , Sampling Studies , Sensitivity and Specificity , Severity of Illness Index , Statistics, Nonparametric , Urinalysis
8.
J Rheumatol ; 28(10): 2269-73, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11669168

ABSTRACT

OBJECTIVE: To investigate the possible role of vascular endothelial growth factor (VEGF) in the pathogenesis of Henoch-Schonlein purpura (IHSP). METHODS: Plasma VEGF levels were determined in 22 children by ELISA. Ten age matched healthy children served as controls. VEGF expression was evaluated by immunohistochemistry within the cutaneous vasculitic lesion as well as the nonaffected skin and in the skin specimens during the resolution of the disease. RESULTS. Plasma VEGF levels in pg/ml (mean +/- SE) were significantly higher during the acute phase (407.8 +/- 64.92) when compared with the levels seen during the resolution phase (202.17 +/- 26.6; p < 0.002) and in healthy controls (135 +/- 22.8; p < 0.001). Analysis showed that there was a correlation with erythrocyte sedimentation rate. C-reactive protein, white blood cell and platelet count. In all skin specimens, the intensity of the staining of VEGF in the epidermis, dermis, and vascular endothelial bed were evaluated and scored from (+) to (++++). VEGF expression in the epidermis and the vascular bed was more intense in resolving lesions compared with acute vasculitic lesions (p < 0.05). CONCLUSION: Our results suggest that as a potent permeability, chemotactic, and migratory factor, VEGF may play a crucial role in the morphological and functional changes of the vascular bed and inflammatory reaction in HSP.


Subject(s)
Endothelial Growth Factors/blood , IgA Vasculitis/blood , Lymphokines/blood , Acute-Phase Reaction/blood , Acute-Phase Reaction/pathology , Blood Sedimentation , C-Reactive Protein/metabolism , Child , Female , Humans , IgA Vasculitis/immunology , IgA Vasculitis/pathology , Leukocyte Count , Male , Platelet Count , Skin/pathology , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
9.
Pediatr Nephrol ; 16(8): 623-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11519890

ABSTRACT

Jeune syndrome is a rare autosomal recessive disease characterized by narrow thoracic cage and short-limbed dwarfism. Seventy percent of affected individuals die in early childhood from pulmonary hypoplasia and respiratory distress due to the small size of the thorax. Growth retardation and chronic renal insufficiency due to nephronophthisis may occur in patients who survive the respiratory failure. We report a family that exhibited clinically heterogeneous features of Jeune syndrome. The 6-year-old male proband presented with skeletal deformities and chronic renal failure. A kidney biopsy revealed that nephronophthisis was the cause of the patient's kidney failure, and we diagnosed Jeune syndrome. A retrospective diagnosis of Jeune syndrome was also established for the proband's older sister, who had died of renal failure at 8 years of age. The oldest female child in the family also had thoracic deformity, and the father and paternal uncle were both of short stature and exhibited brachydactyly. Their renal function and blood pressure were normal. The findings in this family are important in that they demonstrate the clinical heterogeneity of Jeune syndrome and underline the association of renal disease with this syndrome.


Subject(s)
Dwarfism/genetics , Thorax/abnormalities , Child , Dwarfism/complications , Dwarfism/pathology , Fatal Outcome , Female , Humans , Kidney/pathology , Kidney Diseases, Cystic/complications , Kidney Failure, Chronic/etiology , Male , Pedigree , Retrospective Studies , Syndrome
10.
Eur J Hum Genet ; 9(7): 553-5, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11464248

ABSTRACT

Familial Mediterranean Fever (FMF) is a recessive disorder characterised by episodes of fever and neutrophil-mediated serozal inflammation. The FMF gene (MEFV) was recently identified and four common mutations characterised. The aim of this study was to determine the carrier rate in the Turkish population and the mutation frequency in the clinically diagnosed FMF patients. We found a high frequency of carriers in the healthy Turkish population (20%). The distribution of the five most common MEFV mutations among healthy individuals (M694V 3%, M680I 5%, V726A 2%, M694I 0% and E148Q 12%) was significantly different (P<0.005) from that found in patients (M694V 51.55%, M680I 9.22%, V726A 2.88%, M694I 0.44% and E148Q 3.55%).


Subject(s)
Familial Mediterranean Fever/genetics , Heterozygote , Alleles , Female , Gene Frequency , Humans , Male , Mutation , Mutation, Missense , Turkey
11.
Clin Exp Rheumatol ; 19(5 Suppl 24): S68-71, 2001.
Article in English | MEDLINE | ID: mdl-11760405

ABSTRACT

AIM: Apoptosis is a programmed form of cell death. Recently much attention has been devoted to the role of apoptosis in rheumatological diseases. We have aimed to analyze apoptosis in the inflammatory pathway of familial Mediterranean fever (FMF). METHODS: 26 FMF patients and 12 age and sex matched controls were the subject of the study. Twelve of the patients were analyzed during an FMF attack whereas samples were obtained at least a week after an attack in 14. Four of the patients had renal amyloidosis. Whole blood was treated with ammonium chloride for RBC lysis. Subsequently the cells were stained with propidium iodide and annexin. Neutrophils and lymphocytes were gated separately for analysis by flow cytometry. We have also analyzed cellular Fas and Fas-ligand expression in these cells. RESULTS: The mean age of the patients was 12.00 +/- 3.17, and was not different than the control subjects. Erythrocyte sedimentation rate and CRP levels were significantly elevated in the attack group as compared to the attack-free group. The mean levels of neutrophil apoptosis in the FMF patients with an attack, attack-free and controls were 12.94 +/- 11.78, 6.60 +/- 7.83 and 3.98 +/- 4.27, respectively. Lymphocyte apoptosis in the same groups were 7.84 +/- 8.63, 2.75 +/- 2.33, and 1.22 +/- 0.93, respectively. Neutrophil and monocyte apoptosis was significantly increased during the attack as compared to the controls (p < 0.05). However lymphocyte apoptosis was not different between the aforementioned groups. On the other hand, lymphocyte apoptosis was significantly increased in the SLE patients (p < 0.05), whereas neutrophil apoptosis was not. Fas staining of neutrophils were not different between the groups (p > 0.05). On the other hand the difference between the groups for FasL was significant (p < 0.05). CONCLUSION: Neutrophil and monocyte but not lymphocyte apoptosis was significantly increased during FMF attacks reminding us that FMF is an autoinflammation of certain peripheral cells. The increased apoptosis in these patients maybe regarded as a response to clear the unwanted inflammatory cells. On the other hand the increased apoptosis maybe the explanation of the self-limited nature of the FMF attacks. Future studies will enlighten us on the significance of this increased apoptosis in the process of inflammation.


Subject(s)
Apoptosis/physiology , Familial Mediterranean Fever/immunology , Neutrophils/physiology , Adolescent , Blood Sedimentation , C-Reactive Protein , Child , Familial Mediterranean Fever/physiopathology , Female , Flow Cytometry , Humans , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/physiopathology , Male , Monocytes/physiology , Neutrophils/immunology , fas Receptor/analysis , fas Receptor/metabolism
12.
Turk J Pediatr ; 42(2): 148-50, 2000.
Article in English | MEDLINE | ID: mdl-10936982

ABSTRACT

Pulmonary hemosiderosis may rarely be associated with juvenile rheumatoid arthritis or can develop during the course of the disease. We present a three-year-old boy with severe iron deficiency anemia (without any pulmonary symptoms) and arthralgia at the time of diagnosis. Two years after the initial diagnosis he developed pulmonary hemosiderosis and pauciarticular type of juvenile rheumatoid arthritis which progressed to seronegative polyarticular juvenile rheumatoid arthritis. He responded very well to prednisolone and was maintained well on low-dose alternate-day prednisolone and naproxen sodium treatment. This is the only case of association of these two diseases in our experience in both the Pediatric Rheumatology and Pediatric Respiratory Diseases Departments.


Subject(s)
Arthritis, Juvenile/complications , Hemosiderosis/complications , Anemia, Iron-Deficiency/etiology , Anti-Inflammatory Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Juvenile/drug therapy , Child, Preschool , Hemosiderosis/drug therapy , Humans , Male , Naproxen/therapeutic use , Prednisolone/therapeutic use
13.
Pediatr Nephrol ; 14(4): 325-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10775079

ABSTRACT

Renal involvement is common in childhood polyarteritis nodosa (PAN). We report a retrospective analysis of the presentation and clinical course of 26 patients with PAN and renal involvement. The mean age was 9.3 years (range 1-14 years) and there were 12 boys and 14 girls. Renal symptoms at presentation were as follows: 3 had isolated proteinuria, 9 had nephritic syndrome, 2 had nephritic and nephrotic components, and 10 had renal failure with one of the above features. Two patients with isolated hypertension were diagnosed by angiography and classified as classical PAN. Patients either received prednisone p.o. alone (n=9), or prednisone plus cyclophosphamide p.o. (n=11), or pulse steroids with prednisone p.o. and cyclophosphamide (n=2); 4 did not receive any treatment. Patients who were given cyclophosphamide had a significantly better outcome than those who did not. We suggest that oral cyclophosphamide therapy and corticosteroids are effective in the treatment of PAN. The overall 1-year and 5-year survival rates of the patients were 72.5% and 60%, respectively. In conclusion, renal disease is a serious manifestation of PAN necessitating prompt and aggressive treatment.


Subject(s)
Kidney Diseases/etiology , Polyarteritis Nodosa/complications , Adolescent , Antirheumatic Agents/therapeutic use , Child , Child, Preschool , Cyclophosphamide/therapeutic use , Female , Follow-Up Studies , Humans , Infant , Kidney/physiopathology , Kidney Diseases/mortality , Kidney Diseases/physiopathology , Male , Polyarteritis Nodosa/drug therapy , Polyarteritis Nodosa/mortality , Retrospective Studies , Survival Analysis
14.
Clin Exp Rheumatol ; 18(1): 75-7, 2000.
Article in English | MEDLINE | ID: mdl-10728448

ABSTRACT

OBJECTIVE: Hereditary C1q deficiency is a rare disease and up to now only 41 cases have been reported. Since all but 3 cases developed SLE or SLE-like disease, C1q deficiency represents the most powerful disease susceptibility gene identified for the development of SLE in humans. A molecular defect in homozygous C1q deficiency has been identified in 13 families. Four of these families are Turkish in origin and they all share the same mutation which is a CAG to TAG change at codon 186 in the A chain. This led us to investigate whether this mutation might be found in Turkish SLE patients and whether it could cause increased disease susceptibility when expressed in the heterozygous form. METHODS: We screened 65 Turkish lupus patients and 49 healthy Turkish individuals by carrying out an amplification of exon 2 of the A chain and restriction enzyme analysis for the C1qA mutation. RESULTS: We found no other example of this mutation in either the homozygous or heterozygous forms. CONCLUSION: C1q deficiency is one of the very strong disease susceptibility genes in lupus and may cause SLE via a critical role in the physiological clearance of apoptotic cells. However, C1q deficiency caused by a particular mutation in the A chain in a heterozygous form is not found in the Turkish SLE population.


Subject(s)
Complement C1q/deficiency , Complement C1q/genetics , Health Surveys , Lupus Erythematosus, Systemic/genetics , Mutation , Adolescent , Adult , Alleles , Base Sequence/genetics , Child , Female , Heterozygote , Homozygote , Humans , Male , Middle Aged , Turkey
15.
Clin Rheumatol ; 19(6): 486-9, 2000.
Article in English | MEDLINE | ID: mdl-11147763

ABSTRACT

The aetiology of Takayasu's arteritis is unknown, but an association with tuberculosis has been reported. We report the case of a 12-year-old-boy with Takayasu's arteritis: his blood pressure was 150/90 mmHg and fundoscopic examination showed grade I hypertensive changes. A tuberculin test was positive and acid-fast bacteria were seen in the urine. Angiography revealed involvement of the descending aorta, thoracic aorta and upper abdominal aorta, with fusiform enlargement and no filling of the left renal artery. He was started on prednisolone therapy, with cyclophosphamide being added subsequently. Despite vigorous treatment, including three courses of nitroprusside infusion, the severe hypertension persisted and his blood pressure became regulated only after left nephrectomy. Acid-fast bacteria were seen in the nephrectomy material. The exact role of Mycobacterium tuberculosis in the pathogenesis of Takayasu's arteritis is still unknown. In this patient the tuberculin test was positive and acid-fast bacteria were seen in both the urine and nephrectomy material. This finding is suggestive of the association between tuberculosis and the disease process.


Subject(s)
Takayasu Arteritis/diagnostic imaging , Takayasu Arteritis/etiology , Tuberculosis/complications , Aorta/pathology , Aorta/physiopathology , Child , Disease Progression , Humans , Hypertension/diagnostic imaging , Hypertension/drug therapy , Hypertension/etiology , Hypertensive Encephalopathy/drug therapy , Hypertensive Encephalopathy/etiology , Hypertensive Encephalopathy/physiopathology , Male , Renal Artery Obstruction/diagnostic imaging , Renal Artery Obstruction/etiology , Renal Artery Obstruction/surgery , Takayasu Arteritis/drug therapy , Tomography, X-Ray Computed , Treatment Outcome , Tuberculosis/diagnosis
16.
Pediatr Nephrol ; 13(9): 787-9, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10603122

ABSTRACT

Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder. Specific diagnostic criteria for BBS have now been defined. At least four of the five cardinal signs of mental retardation, obesity, hypogenitalism in men, distal limb anomalies, and progressive tapetoretinal degeneration of the retina are required for the diagnosis. Renal involvement has been described as a sixth cardinal feature. Chronic renal failure occurs in 30%-60% of patients. Hypertension has been noted in 50%-66% of cases. Renal abnormalities reflect a defect in maturation of the kidneys. We present a patient with BBS who had bilateral microaneurysms and occlusions in renal arterioles.


Subject(s)
Bardet-Biedl Syndrome/pathology , Kidney/abnormalities , Kidney/blood supply , Aneurysm/pathology , Angiography , Bardet-Biedl Syndrome/complications , Bardet-Biedl Syndrome/diagnostic imaging , Female , Humans , Hypertension/complications , Infant , Kidney/diagnostic imaging
17.
Clin Rheumatol ; 18(4): 304-7, 1999.
Article in English | MEDLINE | ID: mdl-10468170

ABSTRACT

We present the results of antineutrophil cytoplasmic antibody (ANCA) staining in patients with juvenile chronic arthritis (JCA). Thirty-one patients with an age range of 1-16 years were included in the study: 13, 15 and three patients, respectively, were classified having oligoarticular, polyarticular and systemic-onset disease. Indirect immunofluorescence analysis revealed ANCA staining in 45% of the patients. All, except one, revealed atypical pANCA staining. ELISA studies for anti-myeloperoxidase were positive in only one patient with typical pANCA staining. PR-3 ANCA tested negative in all patients. There were no significant correlations between ANCA staining and the clinical parameters of the patients. We conclude that, although the specificity of ANCA in JCA remains to be elucidated, it may be effective in the pathogenesis of the disease.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/analysis , Arthritis, Juvenile/immunology , Adolescent , Antibodies, Antineutrophil Cytoplasmic/immunology , Biomarkers/analysis , Blood Sedimentation , Child , Child, Preschool , Chronic Disease , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique, Indirect , Humans , Immunoglobulin G/immunology , Infant , Male , Severity of Illness Index
18.
Am J Kidney Dis ; 34(1): 140-5, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10401028

ABSTRACT

Polymorphisms of the renin-angiotensin system (RAS) have been shown to affect renal prognosis in a number of diseases. We examined the influence of deletion (D) and insertion (I) polymorphism in the angiotensin I-converting enzyme (ACE) gene and the other polymorphic markers of RAS, and that of plasminogen-activator inhibitor-1 (PAI-1) on renal scarring in reflux nephropathy. Ninety-four children with third- or fourth-degree reflux were the subject of the study. They were stratified into two groups according to the technetium-99m-dimercaptosuccinic acid (DMSA) findings: the first group consisted of 41 patients with no scar formation. In the second group (n = 53), there was significant scar formation in the refluxing units. ACE levels, ACE gene, angiotensin-1 receptor (AT1) A1166C, angiotensinogen (ATG) M235T, and PAI-1 4G/5G polymorphisms were studied. In the second group with scarred kidneys, 18 patients had decreased renal function. The frequency of patients homozygous for the D allele was significantly greater in the second group with scar formation in the refluxing units compared with the first group of patients (P < 0.005). On multivariate analysis, the DD genotype was the only factor that had a significant impact on renal scar formation, introducing a 4.9-fold risk (P < 0.05, 95% confidence interval). We were unable to find any correlation with the presence ofDD genotype and hypertension, decreased renal function, proteinuria, or sex of the patient. DDgenotype correlated with the serum ACE levels (P < 0.005). AT1and ATGpolymorphisms and PAI-1 polymorphism did not correlate with scar formation or any of the parameters. This study provides evidence that the DDgenotype of ACE may be a genetic susceptibility factor contributing to adverse renal prognosis in reflux nephropathy; namely, scar formation. The role of the synergism between the aforementioned genetic polymorphisms can be enlightened with larger patient groups, possibly through multicenter studies.


Subject(s)
Peptidyl-Dipeptidase A/genetics , Polymorphism, Genetic , Vesico-Ureteral Reflux/genetics , Angiotensinogen/genetics , Case-Control Studies , Child , Child, Preschool , Female , Gene Deletion , Genetic Predisposition to Disease , Genotype , Humans , Kidney/pathology , Male , Plasminogen Activator Inhibitor 1/genetics , Receptors, Angiotensin/genetics , Renin-Angiotensin System/genetics , Vesico-Ureteral Reflux/pathology
20.
Turk J Pediatr ; 41(3): 387-90, 1999.
Article in English | MEDLINE | ID: mdl-10770103

ABSTRACT

Familial Mediterranean fever (FMF) is an autosomal recessively transmitted disease characterized by attacks of fever and serositis. The course of arthritis, which is a common manifestation of FMF, is generally benign. Sacroiliitis due to FMF has been reported by several authors, but all the patients described so far had roentgenographic abnormalities, and most of them were adult cases. Here we report the youngest FMF patient with sacroiliitis without any abnormality on sacroiliac x-ray. She is also the first FMF patient in whom sacroiliac involvement was diagnosed by computed tomography (CT) in childhood. It is concluded that CT is a useful technique for the early diagnosis of destructive arthritis in FMF patients even in early childhood.


Subject(s)
Arthritis/etiology , Familial Mediterranean Fever/complications , Sacroiliac Joint/diagnostic imaging , Arthritis/diagnostic imaging , Child, Preschool , Colchicine/therapeutic use , Familial Mediterranean Fever/diagnosis , Familial Mediterranean Fever/drug therapy , Female , Humans , Pain/etiology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...